Taiwan FDA registration bf4225080e276309ab60601b502dad54
"Andoro" abdominal aortic aneurysm stent delivery therapy system
TW: “安多羅”腹主動脈瘤支架暨輸送治療系統
Taiwan·Risk Class 3·Endologix International Holdings B.V;; Endologix, Inc.·Registered Jun 21, 2019 – Jun 21, 2024CancelledRegistration details
- Analysis ID
- bf4225080e276309ab60601b502dad54
- Customs Code
- DHA05603161309
Company information
- Manufacturer Country
- United States;;Netherlands
- Authorized Representative
- GETZ BROS & CO. (BVI), INC., TAIWAN BRANCH
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- E Cardiovascular Medicine Science
- Product Type (Level 2)
- E.0006.
- Import Information
- The use of this device shall comply with the provisions of the Administrative Measures for the Implementation or Use of Medical Devices for Specific Medical Technology Inspection and Testing.
Dates and status
- Registration Date
- Jun 21, 2019
- Expiry Date
- Jun 21, 2024
- Cancellation Date
- Dec 18, 2020
Cancellation information
- Status
- Logged out
- Reason
- 自請註銷
About this record
Access comprehensive regulatory information for "Andoro" abdominal aortic aneurysm stent delivery therapy system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number bf4225080e276309ab60601b502dad54 and manufactured by Endologix International Holdings B.V;; Endologix, Inc.. The authorized representative in Taiwan is GETZ BROS & CO. (BVI), INC., TAIWAN BRANCH.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices